Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2019
Price : $35 *
At a glance
- Drugs Aclerastide (Primary)
- Indications Wounds
- Focus Adverse reactions
- Sponsors US Biotest Inc
- 02 Apr 2019 Status changed from active, no longer recruiting to completed.
- 22 Jan 2019 Planned End Date changed from 1 Oct 2018 to 1 Feb 2019.
- 22 Jan 2019 Status changed from recruiting to active, no longer recruiting.